Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) emerged in late 2019 and resulted in a devastating pandemic. Although the first approved vaccines were already administered by the end of 2020, worldwide vaccine availability is still limited. Mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rand, Ulfert, Kupke, Sascha Young, Shkarlet, Hanna, Hein, Marc Dominique, Hirsch, Tatjana, Marichal-Gallardo, Pavel, Cicin-Sain, Luka, Reichl, Udo, Bruder, Dunja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303422/
https://www.ncbi.nlm.nih.gov/pubmed/34359926
http://dx.doi.org/10.3390/cells10071756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303422/
https://www.ncbi.nlm.nih.gov/pubmed/34359926
http://dx.doi.org/10.3390/cells10071756

Ejemplares similares